NorthView Acquisition Stock Price, News & Analysis
PFSA
NASDAQ
Company Description
Welcome to the overview page for NorthView Acquisition (PFSA), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$0.4805
-1.68%
0.01
Last updated: August 7, 2025 at 04:51
- %
Performance 1 year
$17.4M
Market Cap
32.8M
Shares outstanding
Latest News
SEC Filings
Financial Highlights
�
Revenue (TTM)
�
Net Income (TTM)
�
Diluted EPS (TTM)
�
Operating Cash Flow
�
Net Profit Margin
�
Oper. Profit Margin
Upcoming Events
January 1, 2026 - March 31, 2026
EU Lumee platform launch
Launch of Lumee tissue oxygen monitoring platform in Europe
May 1, 2026 - August 31, 2026
FDA submission for Lumee
U.S. FDA submission for Lumee tissue oxygen platform
January 1, 2027 - December 31, 2027
Lumee platform commercialization
Commercial launch of Lumee tissue oxygen monitoring platform in U.S.
May 1, 2027 - August 31, 2027
Glucose platform commercialization
Commercialization of glucose monitoring platform
Frequently Asked Questions
What is the current stock price of NorthView Acquisition (PFSA)?
The current stock price of NorthView Acquisition (PFSA) is $0.4887 as of August 6, 2025.
What is the market cap of NorthView Acquisition (PFSA)?
The market cap of NorthView Acquisition (PFSA) is approximately 17.4M.